Nicotinamide for high-risk skin cancer patients: An update

Affiliations

¹ Duncan Dermatology - An Affiliate of Golden State Dermatology, St. Helena, California. Electronic address: karyduncan@comcast.net.
² Division of Cardiology, Department of Medicine, UCSF Cardiovascular Care & Prevention Center, University of California San Francisco, San Francisco, California.
³ Department of Dermatology, University of Sydney at Royal Prince Alfred Hospital, Camperdown NSW and Melanoma Institute Australia, North Sydney, NSW, Australia.
⁴ Department of Dermatology, Johns Hopkins Hospital, Baltimore, Maryland; Private Practice, Towson, Maryland.

Editorial

Karynne O Duncan et al. J Am Acad Dermatol. 2024 Dec.

. 2024 Dec;91(6):1301-1302.

doi: 10.1016/j.jaad.2024.08.035. Epub 2024 Sep 19.

¹ Duncan Dermatology - An Affiliate of Golden State Dermatology, St. Helena, California. Electronic address: karyduncan@comcast.net.
² Division of Cardiology, Department of Medicine, UCSF Cardiovascular Care & Prevention Center, University of California San Francisco, San Francisco, California.
³ Department of Dermatology, University of Sydney at Royal Prince Alfred Hospital, Camperdown NSW and Melanoma Institute Australia, North Sydney, NSW, Australia.
⁴ Department of Dermatology, Johns Hopkins Hospital, Baltimore, Maryland; Private Practice, Towson, Maryland.

No abstract available

Keywords: chemoprevention; keratinocyte carcinoma; nicotinamide; skin cancer.

Conflict of interest statement

Conflicts of interest None disclosed.